Related Experiment Video
Updated: Jul 2, 2026

Evaluation of the Cognitive Performance of Hypertensive Patients with Silent Cerebrovascular Lesions
Published on: April 23, 2021
Elevated C-reactive protein is related to cognitive decline in older adults with cardiovascular disease
Karin F Hoth1, Andreana P Haley, John Gunstad
1Department of Medicine, National Jewish Medical and Research Center, Denver, Colorado 80206, USA. hothk@njc.org
Insights
High C-reactive protein (CRP), an inflammation marker, was linked to slight declines in attention and executive function over one year in adults with cardiovascular disease. This suggests inflammation may impact cognitive performance.
Area of Science:
- Gerontology
- Neuroscience
- Cardiovascular Medicine
Background:
- Systemic inflammation, indicated by C-reactive protein (CRP), is increasingly recognized as a factor in age-related cognitive decline.
- Cardiovascular disease (CVD) is associated with heightened inflammatory processes.
- Understanding the link between inflammation and cognition is crucial for developing interventions in aging populations.
Purpose of the Study:
- To prospectively examine the relationship between C-reactive protein (CRP) levels and cognitive changes over a 1-year period.
- To determine if baseline CRP predicts cognitive decline in adults with cardiovascular disease.
Main Methods:
- A prospective, 1-year follow-up study was conducted in an outpatient university medical setting.
- Seventy-eight adults (aged 56-84) with cardiovascular disease were enrolled.
- High-sensitivity C-reactive protein (hs-CRP) levels were measured, and cognitive function was assessed using a neuropsychological battery at baseline and 1-year follow-up.
Main Results:
- High hs-CRP levels were significantly associated with subtle declines in attention-executive-psychomotor performance (CRP beta=-0.22, P=.04) after adjusting for age and baseline cognitive status.
- No significant associations were found between hs-CRP levels and changes in global cognition, language, memory, or visuospatial abilities.
- Hierarchical linear regression modeling was used to analyze the association between CRP and cognitive change across five domains.
Conclusions:
- Preliminary evidence suggests that inflammation, potentially mediated by atherosclerotic processes, may contribute to changes in attention-executive-psychomotor performance.
- Elevated CRP may serve as a biomarker for cognitive changes in individuals with cardiovascular disease.
- Further research is warranted to elucidate the mechanisms linking inflammation and cognitive decline in this population.
Objectives:
To prospectively relate C-reactive protein (CRP), a systemic marker of inflammation, to cognitive change over a 1-year follow-up period.
Design:
Prospective 1-year follow-up.
Setting:
Outpatient university medical setting.
Participants:
Seventy-eight adults (aged 56-84; 39% female) with cardiovascular disease.
Measurements:
CRP levels were measured using a high-sensitivity assay, and participants completed a neuropsychological battery at study entry. Neuropsychological assessment was repeated 1 year later.
Results:
The association between CRP and change in cognition over the 1-year follow-up was examined using hierarchical linear regression modeling for five cognitive domains (global cognition, language, memory, visuospatial abilities, and attention-executive-psychomotor). High CRP levels were associated with subtle declines in attention-executive-psychomotor performance (CRP beta=-0.22, P=.04) after adjusting for the effects of age and cognitive performance at study entry. CRP was not significantly associated with change in language, memory, or visuospatial performance.
Conclusion:
These data provide preliminary evidence that inflammation, potentially contributing to atherosclerotic processes, may underlie the association between high CRP and changes in attention-executive-psychomotor performance.
Related Concept Videos
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Coronary Artery Disease I: Introduction
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Cognitive Development During Adulthood
Psychoneuroimmunology: Cardiovascular Disease
A key area of focus in PNI is the relationship between stress and coronary...
Cardiomyopathy IV: Restrictive Cardiomyopathy